Ruikang Pharmaceutical (002589.SZ) announced that the company received “On Ruikang Pharmaceutical Group Shares...” issued by the Shandong Securities Regulatory Bureau
Zhitong Finance App News, Ruikang Pharmaceutical (002589.SZ) announced that the company received the “Decision on Issuing Warning Letter Measures against Ruikang Pharmaceutical Group Co., Ltd. and related personnel” issued by the Shandong Securities Regulatory Bureau. The relevant information is now announced as follows:
Ruikang Pharmaceutical Group Co., Ltd. and Han Xu, Zhang Renhua, Feng Yun, Li Zhe: After investigation, your company had the following problems: 1. Failure to disclose related transactions, financial support, etc. in accordance with regulations; 2. Failure to promptly disclose major lawsuits and arbitration matters in accordance with regulations. According to Sections 4 and 51 of the “Administrative Measures on Information Disclosure of Listed Companies” (Securities Regulatory Commission Order No. 182), Han Xu as the then-chairman, Zhang Renhua as the current general manager, Feng Yun as the current financial director, and Zhou Yun as the then-board secretary, bear the main responsibility for the first act; Han Xu as the then-chairman and president, Zhang Renhua as the then-general manager, and Zhou Yun as the secretary of the board of directors at the time, is mainly responsible for the second act mentioned above. According to Article 52 of the “Administrative Measures on Information Disclosure of Listed Companies” (Securities Regulatory Commission Order No. 182), our bureau decided to take administrative supervision measures to issue warning letters against your company and Han Xu, Zhang Renhua, Feng Yun, Zhou Yun, and Li Zhe, and record the relevant situation in the securities and futures market integrity file database. You should carefully learn the lessons, strengthen your study of securities laws and regulations, do a good job of disclosing information in accordance with the law, and submit a written report to our bureau within 30 days from the date of receipt of this decision.